Undifferentiated carcinoma of the nasopharyngeal type Material and methods (UCNT) is an intriguing tumour. Although rare in most parts of the world, it occurs with a strikingly high incidence Patients and tissue samples in South East Asia, and is frequent in North Africa and Fresh tumour biopsy specimens were obtained at the time arctic regions (De The, 1980) . Serological and DNA hybridi-of diagnosis from 14 untreated patients with UCNT, most zation studies have shown its association with the Epstein-of them originating from North Africa. Diagnosis of Barr virus (EBV): A close relationship exists between the UCNT was performed by the same pathologist (C.M.) and humoral immune response to EBV antigens and the clinical based upon histological criteria previously described course of the disease (De The et al., 1975; (Shanmugaratnam et al., 1979) . Slides were frozen for 1973). Serum IgA antibodies to the viral capsid antigen immunoperoxidase staining. When allowed by the size of the (VCA) and to early antigens (EA), a typical feature in biops rt was songen ased by mphocyte nasopharyngeal carcinoma (NPC) (Henle et al., 1976) , can biopsy, a part was also gently teased for lymphocyte be used for early diagnosis of the tumour and for detecting recovery on Ficoll cushion in seven cases. In addition individuals at high risk . EBV-specific paraffin-embedded specimens from 29 earlier-diagn od cell-mediated immunity has been less investigated but UCNT patients were retrospectively collected for immuno antibody-dependent cell-mediated cytotoxicity (ADCC) has peroxidase staining with monoclonal antibody HNK 1 been clearly shown to be related to the course and prognosis Antibodies of the disease (Pearson et al., 1978) .
NPC cells express EBV-associated nuclear antigen EBNA Conjugated antisera were from Dako Laboratories, and contain the EBV genome (Wolf et al., 1973; Zur Hausen Denmark. Monoclonal antibodies used included OKT3 to et al., 1970) . However, because no EBV receptor has been the T3 pan-T-cell antigen, OKT4 to the helper/inducer T-cell demonstrated at the surface of any human epithelial cell so subset, OKT8 to the suppressor/cytotoxic subpopulation, far, the mechanism of EBV penetration into nasopharyngeal OKTIO that detects activated T-cells and haematopoietic cells remains a matter of debate (discussed in Rickinson, progenitors (Hercend et al., 1981; Reinherz et al., 1979 ), all 1984 & Wolf, 1984 . Furthermore, the role of the virus in the from Ortho Diagnostics. The Ll/l/12 hybridoma producing carcinogenic process is essentially still not understood.
an anti-HLA-DR monoclonal antibody (Kalil et al., 1982) Typical UCNT histopathologic features consist of a nexus was kindly supplied by George Khalil (Hopital St. Louis, of large epithelial tumour cells and numerous lymphocytes Paris). The HNK-1-producing hybridoma (Abo et al., 1981) ( Shanmugaratnam et al., 1979) . The lymphoid cells within was purchased from the American Type Culture Collection the tumour are cytologically normal, do not contain EBV (Rockville, MD). Anti-Tac monoclonal antibody, that and have been shown to belong largely to the T-lineage detects the IL-2 receptor (Uchiyama et al., 1981; Wakasugi (Gallili et al., 1980 1, a reagent that can be used on paraffin sections (Caillaud ______________________________________________ et al., 1984; Lipinski et al., 1983 HLA-DR antibody) washed in cold PBS, then incubated for 30min with a peroxidase-conjugated rabbit anti-mouse Ig antiserum (diluted 1:100). The reactions were revealed with -H202 and 3-amino-9-ethyl-carbazol or diaminobenzidine. Finally slides were counterstained with haematoxylin for : cytological examination. Detection of Ig-bearing cells was carried out by the same method using a rabbit anti-human Ig antiserum (diluted 1:100) followed by a peroxidase- *>E.,£uR f j2.. 4 In contrast, the number of positive cells could be actually ' , (Figures 1-3) .
Lymphocytes present in the tumour were most often located around groups of malignant cells, but sometimes (Table II) . In all patients the percentage of HNK-1 + from + to + ++. HLA-DR positive lymphocytes were cells was below 15% of total lymphocytes. Approximately present in all specimens from + up to + + ++. In some two-thirds of the sections showed no or very few scattered specimens clear staining of tumour epithelial cells by the stained cells. When more numerous, HNK-1 positive cells anti-HLA-DR antibody was apparent (results not shown).
were located predominantly within the tumour masses. Most (Figure 4 ) typical of human frozen sections (grading explained in the text) NK cells (Saksela et al., 1979) . No study on membrane Tassociated antigens could be performed on these paraffin- T4 positive cells in most patients, T8 positive lymphocytes tended to be predominantly located around tumour cell masses in some patients. The T4/T8 ratio was not strongly correlated with any clinical or biological feature. Because this phenotypically-defined T8 positive subset is known to include the functional population of cytotoxic cells, it is tempting to speculate that the T8 expressing lymphocytes found in close relationship with the malignant cells might play a role in the immune reaction to the tumour. In this regard, it was striking to observe that a relatively high -although varying from one tumour to anotherproportion of T3 positive cells also expressed HLA-DR molecules as detected in double staining assays. In fact 54% (range 12%-90%) of T-cells expressed HLA-DR antigens. This was in agreement with the observation of more numerous HLA-DR positive than sIg bearing cells in lymphocytes isolated from the tumour. The TIO antigen which is also found on activated T-cells (Hercend et al., 1981) was also detected in all tumours tested for this marker. Whether the presence of activated T-cell associated antigens was restricted to the subpopulation expressing the T8 antigen or was rather shared by T4 positive cells as well as suggested by the preliminary results will be a matter for further study.
The reactivity of intra-UCNT lymphocytes was also studied with a monoclonal antibody directed to the receptor for interleukin-2 (IL-2) (Tac antigen) (Uchiyama et al., 1981) , which is only expressed on activated T-cells. Again, in all patients studied we found that a strikingly high number of T-cells (17-28%) although less numerous that T3-HLA-DR positive cells expressed the IL-2 receptor. In addition we have performed bulk cultures of these T-lymphocytes which are easily maintained in IL-2 containing medium. Clones derived from these populations will be necessary to analyze their potentially specific immune functions.
The mechanism of T-cell activation remain to be investigated. Thomas et al. (1984) reported the expression of HLA-DR antigens on NPC epithelial cells by immunoperoxidase labeling. We confirmed this finding in the course of this study. Furthermore we have recently found very high MHCclass II antigen expression on malignant EBNA-positive epithelial cells from nude mice-grown NPC tumours. These malignant NPC cells were shown to produce a monokine able to activate T-cell responses in the presence of mitogens, and probably similar to monocyte-derived interleukin-I (to be reported elsewhere). NPC cells could thus share several characteristics with accessory cells able to induce T-cell activation.
EBNA is the only serologically-defined EBV-associated antigen constantly detected in malignant NPC cells. In infectious mononucleosis (IM), a benign disease caused by a polyclonal activation of B-lymphocytes stimulated by EBV, a cytotoxic immune response is based upon NK and T-cells (Lipinski et al., 1979) . That NK cells, as recognized by the HNK-1 monoclonal antibody, are present in UCNT tumours, might be of relevance for a potential anti-tumour activity in situ. In this context, EBV-specific T-cells could also play a role (Rickinson et al., 1980) , despite the depression of anti-EBV T-cell-mediated immunity observed elsewhere (Moss et al., 1983) in the peripheral blood of NPC patients using the regression of EBV transformation assay. The target structure of EBV-specific cytotoxic T-cells is the LYDMA antigen that has not been serologically defined but whose location in the EBV genome has recently been suggested (Hennesy et al., 1984) . It will be interesting to find out whether UCNT cells can be killed by LYDMA-directed T-cells, and whether lymphocytes isolated from UCNT can give rise to LYDMA-specific cytotoxic T-cell clones.
In conclusion, we have reported that T-cells infiltrating UCNT demonstrate interesting phenotypic features: (i) large variation in the T4/T8 ratio, with usually an excess of T4 positive cells, but with a few striking exceptions. (ii) detection of HNK-1 positive lymphocytes, often with the morphology of LGL, sometimes in high numbers (6 to 15% of the lymphocytes in 9/29 patients), suggesting a role for NK cells in the local defence against UCNT: (iii) constant presence of T-cells expressing HLA-DR antigens, the IL-2 receptor and the TIO antigen, and therefore with the phenotype of activated T-cells.
These data suggest the existence of local immunological reactions in UCNT, involving both T-and NK cells. Further studies will be needed to elucidate their precise nature and their possible role in the control of the disease. Whether the immunological features described in this report can be related with the clinical grades and/or the prognosis of UCNT will be investigated on a large population of patients.
